PMID- 30680373
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231104
IS  - 2577-8285 (Electronic)
IS  - 2577-8285 (Linking)
VI  - 2
IP  - 5
DP  - 2018
TI  - Obstructive sleep apnea and stroke.
PG  - 120-125
AB  - Obstructive Sleep Apnea (OSA) is a common co-morbid condition in stroke patients. 
      It represents a very important risk factor for stroke in addition to the other 
      established ones such as hypertension, cardiovascular disease (CVD), 
      hyperlipidemia, atrial fibrillation (AF), type 2 diabetes mellitus (T2DM), 
      stress, smoking, and heavy drinking. Although in the United States the prevalence 
      of OSA has somewhat decreased from the previous years, globally its prevalence 
      remains constant, or in some cases, is on the rise. In this review we present the 
      epidemiology for OSA in stroke populations and discuss the risk factors for 
      stroke as well as the underlying pathogenetic mechanisms linking OSA, stroke and 
      CVD. We also emphasize the more thorough evaluation and control of OSA in order 
      to prevent the disabling side effects of a stroke, which not only compromises the 
      physical and mental health of a person and increases the burden on families, but 
      also adds a severe burden to national health economics. OSA should always be 
      considered when assessing a patient with transient ischemic attacks (TIA). Work 
      up and treatment for OSA will not only help prevent stroke with its devastating 
      consequences, but will also help prevent CVD, and ameliorate co-morbid conditions 
      such as diabetes and hypertension in these vulnerable populations.
FAU - Jehan, Shazia
AU  - Jehan S
AD  - Department of Population Health, New York University School of Medicine, USA.
FAU - Farag, Mahmoud
AU  - Farag M
AD  - Department of Surgery, SUNY Downstate Medical Center, USA.
FAU - Zizi, Ferdinand
AU  - Zizi F
AD  - Department of Population Health, New York University School of Medicine, USA.
FAU - Pandi-Perumal, Seithikurippu R
AU  - Pandi-Perumal SR
AD  - Somnogen Canada Inc., College Street, Canada.
FAU - Chung, Alicia
AU  - Chung A
AD  - Department of Population Health, New York University School of Medicine, USA.
FAU - Truong, Anrew
AU  - Truong A
AD  - Department of Medicine, SUNY Downstate Medical Center, USA.
FAU - Jean-Louis, Girardin-
AU  - Jean-Louis G
AD  - Department of Population Health, New York University School of Medicine, USA.
FAU - Tello, Daniela
AU  - Tello D
AD  - Department of Medicine, SUNY Downstate Medical Center, USA.
FAU - McFarlane, Samy I
AU  - McFarlane SI
AD  - Department of Medicine, SUNY Downstate Medical Center, USA.
LA  - eng
GR  - R01 MD007716/MD/NIMHD NIH HHS/United States
GR  - R25 HL105444/HL/NHLBI NIH HHS/United States
GR  - R25 HL116378/HL/NHLBI NIH HHS/United States
GR  - T32 HL129953/HL/NHLBI NIH HHS/United States
PT  - Journal Article
DEP - 20181130
PL  - United States
TA  - Sleep Med Disord
JT  - Sleep medicine and disorders : international journal
JID - 101719069
PMC - PMC6340906
MID - NIHMS1004011
OTO - NOTNLM
OT  - CPAP
OT  - OSA
OT  - atrial fibrillation
OT  - cardiovascular disease
OT  - dyslipidemia
OT  - hypertension
OT  - polysomnography
OT  - sleep
OT  - stroke
OT  - transient ischemic attacks
COIS- Conflicts of interest The author declares that there is no conflicts of interest.
EDAT- 2019/01/27 06:00
MHDA- 2019/01/27 06:01
PMCR- 2019/01/22
CRDT- 2019/01/26 06:00
PHST- 2019/01/26 06:00 [entrez]
PHST- 2019/01/27 06:00 [pubmed]
PHST- 2019/01/27 06:01 [medline]
PHST- 2019/01/22 00:00 [pmc-release]
PST - ppublish
SO  - Sleep Med Disord. 2018;2(5):120-125. Epub 2018 Nov 30.